Skip to Content
U.S. National Institutes of Health
Last Updated: 07/22/11

Selected RRP Staff Publications

  1. New Translational Possibilities for Microenvironmental Modulation of Radiosensitivity.
    Glazer PM, Le QT, Bristow R, Helleday T, Pelroy R, Bernhard EJ.Radiat Res. 2011 Jul 8. [Epub ahead of print] PMID: 21740252

  2. Disaster preparation: lessons from Japan.
    Coleman CN, Simon SL, Noska MA, Telfer JL, Bowman T. Science. 2011 Jun 17;332(6036):1379. PMID:21680826

  3. Unaltered ethical standards for individual physicians in the face of drastically reduced resources resulting from an improvised nuclear device event.
    Caro JJ, Coleman CN, Knebel A, DeRenzo EG.
    J Clin Ethics. 2011 Spring;22(1):33-41. PMID: 21595353

  4. Preparing and planning for a catastrophic incident of a nuclear detonation. Foreword. Coleman CN, Knebel AR, Lurie N. Disaster Med Public Health Prep. 2011 Mar;5 Suppl 1:S11-2. PMID: 21402802

  5. Scarce resources for nuclear detonation: project overview and challenges.
    Coleman CN, Knebel AR, Hick JL, Weinstock DM, Casagrande R, Caro JJ, DeRenzo EG, Dodgen D, Norwood AE, Sherman SE, Cliffer KD, McNally R, Bader JL, Murrain-Hill P.
    Disaster Med Public Health Prep. 2011 Mar;5 Suppl 1:S13-9. PMID: 21402805

  6. Biological Dosimetry by the Triage Dicentric Chromosome Assay: Potential Implications for Treatment of Acute Radiation Syndrome in Radiological Mass Casualties.
    Romm H, Wilkins RC, Coleman CN, Lillis-Hearne PK, Pellmar TC, Livingston GK, Awa AA, Jenkins MS, Yoshida MA, Oestreicher U, Prasanna PG. Radiat Res. 2011 Jan 4. [Epub ahead of print] PMID: 21204674

  7. Establishment of a Radiogenomics Consortium
    West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, Coles C, De Ruyck K, De Ruysscher D, Dunning A, Elliott R, Fachal L, Hall J, Haustermans K, Herskind C, Hoelscher T, Imai T, Iwakawa M, Jones D, Kulich C; EQUAL-ESTRO, Langendijk JH, O’Neils P, Ozsahin M, Parliament M, Polanski A, Rosenstein B, Seminara D, Symonds P, Talbot C, Thierens H, Vega A, West C, Yarnold J. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1295-6. PMID: 20338472

    This report describes the formation of a Radiogenomics Consortium established to aid in the identification of genetic variants, primarily single nucleotide polymorphisms (SNPs), associated with the development of normal tissue toxicities resulting from radiation therapy.

  8. A Small Interfering RNA Screen of Genes Involved in DNA Repair Identifies Tumor-Specific Radiosensitization by POLQ Knockdown
    Higgins GS, Prevo R, Lee YF, Helleday T, Muschel RJ, Taylor S, Yoshimura M, Hickson ID, Bernhard EJ, McKenna WG. Cancer Res. 2010 Mar 16. [Epub ahead of print]PMID: 20233878

    This publication describes a novel method for high throughput screening for synthetic lethality of molecular targeting combined with radiation. The DNA repair enzyme Pol Q is newly identified as a contributor to tumor cell survival after irradiation.

  9. Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy
    Maity A, Bernhard EJ. Cancer Res. 2010 Mar 15;70(6):2141-5. Epub 2010 Feb 23.PMID: 20179191

    This review describes new findings that inhibition of tumor cell signaling can enhance tumor response to radiation and cytotoxic drugs by enhancing vascular function and tumor oxygenation.

  10. Triage dose assessment for partial-body exposure: dicentric analysis
    Prasanna PG, Moroni M, Pellmar TC. Health Phys. 2010 Feb;98(2):244-51.PMID: 20065689

  11. Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines
    Lu TP, Lai LC, Lin BI, Chen LH, Hsiao TH, Liber HL, Cook JA, Mitchell JB, Tsai MH, Chuang EY. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):212-9.PMID: 20005454

  12. Improving cancer outcomes through international collaboration in academic cancer treatment trials.
    Trimble EL, Abrams JS, Meyer RM, Calvo F, Cazap E, Deye J, Eisenhauer E, Fitzgerald TJ, Lacombe D, Parmar M, Seibel N, Shankar L, Swart AM, Therasse P, Vikram B, von Frenckell R, Friedlander M, Fujiwara K, Kaplan RS, Meunier F. J Clin Oncol. 2009 Oct 20;27(30):5109-14. Review.PMID: 19720905

  13. Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources
    Vikram B, Coleman CN, Deye JA. Oncology (Williston Park). 2009 Mar;23(3):279-83. Review. PMID: 19418829

  14. Current status and future potential of advanced technologies in radiation oncology. Part 2. State of the science by anatomic site
    Vikram B, Coleman CN, Deye JA. Oncology (Williston Park). 2009 Apr 15;23(4):380-5.PMID: 19476269

  15. Re: Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems
    Deye J, Purdy J, Vikram B. J Natl Cancer Inst. 2008 Sep 3;100(17):1263-4; author reply 1265-7. Epub 2008 Aug 26. PMID: 18728288

  16. Radiation event medical management (REMM): website guidance for health care providers
    Bader JL, Nemhauser J, Chang F, Mashayekhi B, Sczcur M, Knebel A, Hrdina C, Coleman CN. Prehosp Emerg Care. 2008 Jan-Mar;12(1):1-11.PMID: 18189170